Prostate Cancer
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis.
November 30, 2023
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
November 30, 2023
Actigraphy-derived measures of sleep and risk of prostate cancer in the UK Biobank.
November 30, 2023
Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer.
November 30, 2023
Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
November 29, 2023
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?
November 29, 2023
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
November 29, 2023
Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+ T cell.
November 29, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
November 29, 2023
Age 70 +/− 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review
November 28, 2023
The Cardiovascular Effects of Gonadotropin-Releasing Hormone Antagonists in Men with Prostate Cancer
November 28, 2023
SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
November 28, 2023
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction.
November 28, 2023
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.
November 28, 2023